Primary Outcome
Primary Outcome
HS treatment (n=26) HS treatment (n=26) HS treatment (n=26)
Conventional treatment (n=26)
Conventional treatment (n=26)
Conventional treatment (n=26)
P value
Pre ACT
Post ACT
Mean Improvement
Pre ACT Post ACT
Mean Improvement
Mean Predicted FEV1 (%) Phase I 64.35 78.50 14.15±5.50 70.42 65.38 5.04±5.55 0.000
Phase II 72.92 62.12 10.81±5.51 71.19 74.73 3.54±5.13 0.001
Mean Predicted FVC (%) Phase I 63.88 77.65 13.77±5.73 63.30 70.84 7.54±4.90 0.000
Phase II 62.11 71.53 9.42±7.00 68.58 73.00 4.42±4.00 0.003
Secondary Outcome
Secondary Outcome
HS treatment (n=26) HS treatment (n=26) HS treatment (n=26)
Conventional treatment (n=26)
Conventional treatment (n=26)
Conventional treatment (n=26)
Mean Number of exacerbations/child/ year Phase I 2.50±0.64 2.50±0.64 2.50±0.64 7.80±1.05 7.80±1.05 7.80±1.05 0.001
Phase II 3.90±0.74 3.90±0.74 3.90±0.74 6.20±0.77 6.20±0.77 6.20±0.77 0.074